# Hormone Treatment in Growth Hormone and Testosterone Deficient Patients

> **NCT01397500** · PHASE2 · TERMINATED · sponsor: **Max-Planck-Institute of Psychiatry** · enrollment: 54 (actual)

## Conditions studied

- Hormone Deficiency

## Interventions

- **DRUG:** Genotropin
- **DRUG:** Testosterone undecannoate

## Key facts

- **NCT ID:** NCT01397500
- **Lead sponsor:** Max-Planck-Institute of Psychiatry
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-11
- **Primary completion:** 2015-02
- **Final completion:** 2015-03
- **Target enrollment:** 54 (ACTUAL)
- **Why stopped:** Recruitment problems due to change of patient population at site.
- **Last updated:** 2016-01-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01397500

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01397500, "Hormone Treatment in Growth Hormone and Testosterone Deficient Patients". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT01397500. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*